Stock Analysis

Is There Now An Opportunity In Fras-le S.A. (BVMF:FRAS3)?

BOVESPA:FRAS3
Source: Shutterstock

Fras-le S.A. (BVMF:FRAS3), is not the largest company out there, but it received a lot of attention from a substantial price movement on the BOVESPA over the last few months, increasing to R$15.56 at one point, and dropping to the lows of R$12.17. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Fras-le's current trading price of R$12.17 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Fras-le’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

See our latest analysis for Fras-le

What is Fras-le worth?

According to my valuation model, Fras-le seems to be fairly priced at around 3.84% above my intrinsic value, which means if you buy Fras-le today, you’d be paying a relatively fair price for it. And if you believe the company’s true value is R$11.72, then there isn’t really any room for the share price grow beyond what it’s currently trading. Is there another opportunity to buy low in the future? Since Fras-le’s share price is quite volatile, we could potentially see it sink lower (or rise higher) in the future, giving us another chance to buy. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

Can we expect growth from Fras-le?

earnings-and-revenue-growth
BOVESPA:FRAS3 Earnings and Revenue Growth January 28th 2022

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. However, with a negative profit growth of -14% expected over the next couple of years, near-term growth certainly doesn’t appear to be a driver for a buy decision for Fras-le. This certainty tips the risk-return scale towards higher risk.

What this means for you:

Are you a shareholder? Currently, FRAS3 appears to be trading around its fair value, but given the uncertainty from negative returns in the future, this could be the right time to reduce the risk in your portfolio. Is your current exposure to the stock beneficial for your total portfolio? And is the opportunity cost of holding a negative-outlook stock too high? Before you make a decision on the stock, take a look at whether its fundamentals have changed.

Are you a potential investor? If you’ve been keeping tabs on FRAS3 for a while, now may not be the most optimal time to buy, given it is trading around its fair value. The price seems to be trading at fair value, which means there’s less benefit from mispricing. Furthermore, the negative growth outlook increases the risk of holding the stock. However, there are also other important factors we haven’t considered today, which can help gel your views on FRAS3 should the price fluctuate below its true value.

So while earnings quality is important, it's equally important to consider the risks facing Fras-le at this point in time. For example - Fras-le has 4 warning signs we think you should be aware of.

If you are no longer interested in Fras-le, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.